Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M27.7Revenue (TTM) $M0.6Net Margin (%)-487.3Altman Z-Score--
Enterprise Value $M27.3EPS (TTM) $-0.8Operating Margin %31.6Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-283.2Higher ROA y-yN
Price/Book1.710-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales30.95-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow1.5y-y EBITDA Growth Rate %-74.1ROA % (ttm)-12.4Higher Current Ratio y-yN
Dividend Yield %0.4PEG--ROE % (ttm)-18.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M3.8ROIC % (ttm)1.1Gross Margin Increase y-yN

Gurus Latest Trades with DXR

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

DXR is held by these investors:



DXR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
FELDSCHUH JOSEPHChairman, 10% Owner 2017-01-04Sell48,500$8.5-16.47view
FELDSCHUH JOSEPHChairman, 10% Owner 2017-01-04Buy172,000$8.5-16.47view
Feldschuh Michael RichardActing CEO & President 2016-04-15Buy300$8.06-11.91view
Feldschuh Michael RichardActing CEO & President 2016-04-14Buy200$8.07-12.02view
Feldschuh Michael RichardActing CEO & President 2016-04-11Buy200$8.06-11.91view
Feldschuh Michael RichardExecutive VP 2016-04-07Buy100$8.08-12.13view
Feldschuh Michael RichardExecutive VP 2015-08-12Buy500$6.2214.15view
Feldschuh Michael RichardExecutive VP 2015-08-06Buy200$6.548.56view
Feldschuh Michael RichardExecutive VP 2015-08-04Buy583$6.499.4view
Feldschuh Michael RichardExecutive VP 2015-07-28Buy500$6.489.57view

Press Releases about DXR :

Quarterly/Annual Reports about DXR:

    News about DXR:

    Articles On GuruFocus.com
    Daxor Corporation Announces Hiring of Chief Financial Officer Jun 17 2016 
    Real-World Impact on Heart Failure Mortality and Readmissions of Individualized Care Guided by Blood Apr 06 2016 
    University of Hawaii and The Queen's Medical Center Reports on a Study on Critically Ill Patients Ut Mar 09 2016 
    Daxor Corporation Announces Upcoming Filing of Form N-CSR for December 31, 2015 and Recent Developme Feb 29 2016 
    Daxor Corporation Announces Return of Dr. Joseph Feldschuh After Pancreatic Cancer Surgery Feb 17 2016 
    Daxor Corporation Announces Sale of BVA-100 Blood Volume Analyzer to Nebraska Medicine Feb 08 2016 
    Daxor Corporation Announces an Increased Dividend and the Appointment of Michael Feldschuh as Presid Dec 10 2015 
    Heart Failure Research From the Mayo Clinic Utilizing the BVA-100 Blood Volume Analyzer Presented at Oct 01 2015 
    Taglich Brothers Initiates Coverage of Daxor Corporation Sep 04 2015 
    Daxor Announces Hire of Senior Vice President, Marketing and Commercial Development Sep 02 2015 

    More From Other Websites
    Daxor Corporation Announces Delay in Filing of Form N-CSR for December 31, 2016, and the Uniformed... Apr 10 2017
    Daxor Corporation Announces Death of Founder, Chief Medical Officer, and Developer of Blood Volume... Feb 01 2017
    SCCM17 Randomized Controlled Trial Analysis: Individualized Volume Management Guided by Direct Blood... Jan 30 2017
    ETFs with exposure to Daxor Corp. : January 19, 2017 Jan 19 2017
    Huge Michael Dell Purchase Highlights Insider Buying: Dell Technologies, Accelerate Diagnostics,... Jan 15 2017
    Daxor Corporation Announces Dividend, Patent Approval, Title Change Nov 18 2016
    Daxor Corporation Announces Two New Studies From the Mayo Clinic and Lankenau Medical Center... Sep 29 2016
    Daxor Corp. :DXR-US: Earnings Analysis: For the six months ended June 30, 2016 : September 27, 2016 Sep 27 2016
    Daxor Corporation Announces Filing of Form N-CSR for June 30, 2016 Sep 15 2016
    In Heart Failure, One Size Does Not Fit All: New Mayo Clinic BVA Study Published in Journal of the... Jul 27 2016
    Daxor Corporation Announces Hiring of Chief Financial Officer Jun 17 2016
    Real-World Impact on Heart Failure Mortality and Readmissions of Individualized Care Guided by Blood... Apr 06 2016
    University of Hawaii and The Queen's Medical Center Reports on a Study on Critically Ill Patients... Mar 09 2016
    Daxor Corporation Announces Upcoming Filing of Form N-CSR for December 31, 2015 and Recent... Feb 29 2016
    Daxor Corporation Announces Return of Dr. Joseph Feldschuh After Pancreatic Cancer Surgery Feb 17 2016
    Daxor Corporation Announces Sale of BVA-100 Blood Volume Analyzer to Nebraska Medicine Feb 08 2016
    Technical Data Drives the Market - Analyst Review of Orkla, Magic Software Enterprises, Iao Kun... Jan 29 2016
    Daxor Corporation Announces an Increased Dividend and the Appointment of Michael Feldschuh as... Dec 10 2015
    Daxor Corporation Announces Filing of Form N-Q for September 30, 2015 Nov 27 2015
    Second Heart Failure Study From the Mayo Clinic Utilizing Daxor's BVA-100 Blood Volume Analyzer... Nov 25 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)